ClinicalTrials.gg
RecruitingNCT06910930Updated Jan 21, 2026

Impact of Muscle Training Device on Non-Severe OSA

An interventional study of DidgeriTU and Sham device in OSA and Obstructive Sleep Apnea, sponsored by Thammasat University Hospital. Recruiting at 1 site in Thailand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by Thammasat University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Sleep Apnea, Obstructive with a site in Thailand — 4 open to participants now, 4 under way, none of them phase 3. Sleep Apnea, Obstructive · Thailand.

Planned enrollment
3rd of 12
76 · median 36
Started
2025
with 1 other
No phase
10 of 15
2 open now
Registered
11th of 15
by date
Lead sponsor
2 of 15
Thammasat University Hospital

Among the 15 studies in Sleep Apnea, Obstructive with a site in Thailand, this one is the 3rd largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2025, is one of 10 with no phase, and was the 11th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

4 of the 15 studies in Sleep Apnea, Obstructive with a site in Thailand are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Thailand have not opened yet or have stopped. Only those recruiting at a site in Thailand →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Sleep Apnea, Obstructive with a site in Thailand, or all of them as a file.
02

Study summary

The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is:

  • Can DidgeriTU reduce apnea events in patients with non-severe obstructive sleep apnea? Researchers will compare DidgeriTU with a sham device to see how the apnea event has changed.

Participants will:

  • Use DidgeriTU or sham device for 3 month
  • Do an online questionnaire once a month during the study
  • Home sleep test, lung function test, and tongue strength test at the start and end of the study
Read the detailed description

Previously, in Switzerland, an aboriginal musical instrument, the Didgeridoo, was taught to patients with OSA. It has been proven to be effective in reducing apnea events.

Our newly invented instrument, DidgeriTU, adopts the Didgeridoo principle for expiratory muscle exercise to reduce apnea events.

03

Conditions studied

  • OSA
  • Obstructive Sleep Apnea

Keywords

  • Device
  • EMST
  • Powerbreathe
  • didgeridoo
  • didgeriTU
  • Expiratory muscle exercise
  • reverse CPAP
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with mild to moderate obstructive sleep apnea.
  • Age 18 years or older.
  • Patients voluntarily consent to provide information for research purposes.

Exclusion criteria

Exclusion Criteria:

  • Patients with an average apnea-hypopnea index (AHI) of \<4 or >29 events per hour after repeated diagnosis using a home sleep apnea test.
  • Patients who refused to cease using CPAP during the study process
  • Patients with a history of chronic lung disease.
  • Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders.
  • Patients taking medications that may affect muscle function within 3 months before the start of the study.
  • Patients with hypothyroidism or other conditions that may affect muscle function.
  • Patients who consume alcohol at a moderate level or higher
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Active comparator
    DidgeriTU

    patients with non severe OSA using DidgeriTU device

    Device: DidgeriTU

  • Sham comparator
    sham device

    Patients with non severe OSA receive a device that look alike didgeriTU but without resistance plate

    Device: Sham device

Interventions

  • DeviceDidgeriTU

    the study device that immitate the principle of didgeridoo for expiratory muscle exercise

  • DeviceSham device

    a device that look alike DidgeriTU but without resistance plate

06

What researchers measure

Primary outcomes

  1. Change of apnea event after DidgeriTU usage compared with sham device

    Participants with a known history of non-severe obstructive sleep apnea will repeat the home sleep apnea test. The study will include patients with non-severe OSA(Apnea-hypopnea index 5-29/hr) from HSAT. After the usage of DidgeriTU or sham device for 3 months, the participant will repeat HSAT to explore the change of AHI after DidgeriTU use compared with sham device.

    Time frame: 3 months

Secondary outcomes

  1. Change of OSA severity after the usage of DidgeriTU comparing with sham device

    Participants with a known history of non-severe obstructive sleep apnea will repeat the home sleep apnea test. The study will include patients with non-severe OSA(Apnea-hypopnea index 5-29/hr.) from HSAT and categorize patients with AHI 5-14/hr as mild OSA, AHI 15-29/hr as moderate OSA. After the usage of DidgeriTU or sham device for 3 months, the participant will repeat HSAT to explore the change of OSA severity after DidgeriTU use compared with sham device.

    Time frame: 3 months

  2. Change in Epworth sleepiness scale after the usage of DidgeriTU comparing with sham device

    The participants' daytime sleepiness will be evaluated at the beginning of the study by the Thai version of the Epworth sleepiness scale then followed up with an online questionnaire every month until the end of the study. The total ESS score ranges from 0 to 24, with higher scores indicating greater daytime sleepiness. The change in ESS in patients using DidgeriTU will be compared with patients using sham devices.

    Time frame: 3 months

  3. Change of maximum inspiratory pressure; MIP after DidgeriTU usage comparing with sham device

    The participants' maximum inspiratory pressure; MIP will be measured at the beginning and end of the study to compare the effect of DidgeriTU and sham device with inspiratory muscle which will be reported in cmH2O.

    Time frame: 3 months

  4. Change of maximum expiratory mouth pressure; MEP after DidgeriTU usage comparing with sham device

    The participants' maximum expiratory mouth pressure; MEP will be measured at the beginning and end of the study to compare the effect of DidgeriTU and sham device with expiratory muscle which will be reported in cmH2O.

    Time frame: 3 months

  5. change in Pittsburg Sleep Quality Index; PSQI after DidgeriTU usage comparing with sham device

    The participants' sleep quality will be evaluated at the beginning of the study by the Thai version of the Pittsburg sleep quality index then followed up with an online questionnaire every month until the end of the study. The global PSQI score ranges from 0 to 21, where lower scores indicate better sleep quality. The change in PSQI in patients using DidgeriTU will be compared with patients using sham devices.

    Time frame: 3 months

  6. Change of snoring frequency after DidgeriTU usage compared with a sham device

    The snoring index (events/hour) will be recorded from HSAT at the beginning and end of the study. The change of snoring index from patients using DidgeriTU and sham device will be compared.

    Time frame: 3 months

  7. change of oxygenation during sleep after DidgeriTU usage comparing with sham device

    The average oxygen saturation (%) will be recorded from HSAT at the beginning and end of the study. The change in average oxygen saturation from patients using DidgeriTU and sham device will be compared.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Mar 2026, 10 months after the start.

Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 10 months is below that.

Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 19, 2025
First posted
Apr 4, 2025
StartActual
May 1, 2025
Primary completionEst.
Mar 15, 2026
CompletionEst.
Mar 15, 2026
Last update
Jan 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06910930
Lead sponsor
Thammasat University Hospital
Responsible party
Naphitchaya Wiriya (Naphitchaya Wiriya, MD., Thammasat University) — Principal investigator
First posted
Apr 4, 2025
Start date
May 1, 2025
Primary completion
Mar 15, 2026 (estimated)
Completion
Mar 15, 2026 (estimated)
Last update
Jan 21, 2026

Study contacts

Naphitchaya Wiriya, Internal medicine
Contact
jazhana@gmail.com
+66870883390

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion